Menu
GWAS Study

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Swaminathan B, Thorleifsson G, Jöud M et al.

26007630 PubMed ID
GWAS Study Type
227446 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SB
Swaminathan B
TG
Thorleifsson G
JM
Jöud M
AM
Ali M
JE
Johnsson E
AR
Ajore R
SP
Sulem P
HB
Halvarsson BM
EG
Eyjolfsson G
HV
Haraldsdottir V
HC
Hultman C
IE
Ingelsson E
KS
Kristinsson SY
KA
Kähler AK
LS
Lenhoff S
MG
Masson G
MU
Mellqvist UH
MR
Månsson R
NS
Nelander S
OI
Olafsson I
SO
Sigurðardottir O
SH
Steingrimsdóttir H
VA
Vangsted A
VU
Vogel U
WA
Waage A
NH
Nahi H
GD
Gudbjartsson DF
RT
Rafnar T
TI
Turesson I
GU
Gullberg U
SK
Stefánsson K
HM
Hansson M
TU
Thorsteinsdóttir U
NB
Nilsson B
Chapter II

Abstract

Summary of the research findings

Multiple myeloma (MM) is characterized by an uninhibited, clonal growth of plasma cells. While first-degree relatives of patients with MM show an increased risk of MM, the genetic basis of inherited MM susceptibility is incompletely understood. Here we report a genome-wide association study in the Nordic region identifying a novel MM risk locus at ELL2 (rs56219066T; odds ratio (OR)=1.25; P=9.6 × 10(-10)). This gene encodes a stoichiometrically limiting component of the super-elongation complex that drives secretory-specific immunoglobulin mRNA production and transcriptional regulation in plasma cells. We find that the MM risk allele harbours a Thr298Ala missense variant in an ELL2 domain required for transcription elongation. Consistent with a hypomorphic effect, we find that the MM risk allele also associates with reduced levels of immunoglobulin A (IgA) and G (IgG) in healthy subjects (P=8.6 × 10(-9) and P=6.4 × 10(-3), respectively) and, potentially, with an increased risk of bacterial meningitis (OR=1.30; P=0.0024).

2,194 European ancestry cases, 222,555 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

227446
Total Participants
GWAS
Study Type
Yes
Replicated
586 European ancestry cases, 2,111 European ancestry controls
Replication Participants
European
Ancestry
Sweden, Denmark, Iceland, Norway
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.